Selected Cell
Cell:
Value:
CEL
OOC
AB
D.IMG
RNA
D.PCR
D.LMX
D.ELSA
A.IMG
A
B
C
D
E
F
G
H
I
J
K
L
M
N
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | Name | Protocol | Species | Source | Media | Scientist | Type | Disease | Parent | Treatment1 | Treatment1Dose | Treatment1DoseUnits | Treatment1Reference |
| CEL-230131KAM-1 | NHLF | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Homo sapiens | Lonza, CC-2512 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Kamm Lab | Fibroblasts (normal lung) | ||||||
| CEL-250519KAM-1 | HUVEC_C2519A | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Homo sapiens | Lonza, CC-C2519A | VascuLife VEGF Endothelium Medium Complete Kit, Lifeline | Elena Cambria | Endothelial (HUVEC) | ||||||
| CEL-250519KAM-2 | NHLF_Myofibroblasts | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Homo sapiens | Elena Cambria | Myofibroblast | CEL-230131KAM-1 | TGF-B1 | 1 | ng/ml | https://www.thermofisher.com/proteins/product/Human-TGF-beta-1-Recombinant-Protein/100-21-10UG | |||
| CEL-250519KAM-3 | NHLF_Control | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Homo sapiens | Elena Cambria | CEL-230131KAM-1 | Control | 0 | ||||||
| CEL-251118KAM-1 | H337 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | Healthy | |||||
| CEL-251118KAM-2 | H510 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | Healthy | |||||
| CEL-251118KAM-3 | H543 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | Healthy | |||||
| CEL-251118KAM-4 | D013 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | IPF | |||||
| CEL-251118KAM-5 | D706 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | IPF | |||||
| CEL-251118KAM-6 | D738 | P.KAM-251118-V1_EC_Myofibroblast_IPF.docx | Homo sapiens | See Table 1 | FibroLife S2 Fibroblast Medium Complete Kit, Lifeline | Elena Cambria | Human Primary Fibroblasts | IPF | |||||
A
B
C
D
E
F
G
H
I
J
K
L
M
N
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
| UID | Name | Parent | ExperimentType | Vascularization | Scientist | Protocol | Material | Media | Treatment1 | Treatment1Dose | Treatment1DoseUnits | Treatment1Reference | Treatment1Protocol |
| OOC-250519KAM-1 | Fig3 Exp1 Control01 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-2 | Fig3 Exp1 Control02 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-3 | Fig3 Exp1 Treated01 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-4 | Fig3 Exp1 Treated02 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-5 | Fig3 Exp2 ECM_Control_001 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-6 | Fig3 Exp2 ECM_Control_002 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-7 | Fig3 Exp2 ECM_Treated_001 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-8 | Fig3 Exp2 ECM_Treated_002 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-9 | Fig3 Exp2 S1_Control_001 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-10 | Fig3 Exp2 S1_Control_002 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-11 | Fig3 Exp2 S1_Treated_001 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-12 | Fig3 Exp2 S1_Treated_002 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-13 | Fig3 Exp3 ECM_Control_001 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-14 | Fig3 Exp3 ECM_Control_002 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-15 | Fig3 Exp3 ECM_Treated_001 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-16 | Fig3 Exp3 ECM_Treated_002 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-17 | Fig3 Exp3 S1_Control_001 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-18 | Fig3 Exp3 S1_Control_002 | CEL-250519KAM-3 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-19 | Fig3 Exp3 S1_Treated_001 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-20 | Fig3 Exp3 S1_Treated_002 | CEL-250519KAM-2 | Imaging | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | ||||||
| OOC-250519KAM-21 | Fig4 Exp1 Treated_A | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-22 | Fig4 Exp1 Control_A | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-23 | Fig4 Exp1 Control_B | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-24 | Fig4 Exp1 Control_C | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-25 | Fig4 Exp1 Control_D | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-26 | Fig4 Exp1 Treated_B | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-27 | Fig4 Exp1 Treated_C | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-28 | Fig4 Exp1 Treated_D | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-29 | Fig4 Exp2 Control_A | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-30 | Fig4 Exp2 Control_B | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-31 | Fig4 Exp2 Control_C | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-32 | Fig4 Exp2 Control_D | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-33 | Fig4 Exp2 Treated_A | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-34 | Fig4 Exp2 Treated_B | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-35 | Fig4 Exp2 Treated_C | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-36 | Fig4 Exp2 Treated_D | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-37 | Fig4 Exp3 Control_A | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-38 | Fig4 Exp3 Control_B | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-39 | Fig4 Exp3 Control_C | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-40 | Fig4 Exp3 Control_D | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-41 | Fig4 Exp3 Treated_A | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-42 | Fig4 Exp3 Treated_B | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-43 | Fig4 Exp3 Treated_C | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-44 | Fig4 Exp3 Treated_D | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Angiogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-45 | Fig5 Exp1 Control C001 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-46 | Fig5 Exp1 Control C002 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-47 | Fig5 Exp1 Control C003 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-48 | Fig5 Exp1 Control C004 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-49 | Fig5 Exp1 Treated T001 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-50 | Fig5 Exp1 Treated T002 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-51 | Fig5 Exp1 Treated T003 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-52 | Fig5 Exp1 Treated T004 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-53 | Fig5 Exp2 Control A | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-54 | Fig5 Exp2 Control B | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-55 | Fig5 Exp2 Control C | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-56 | Fig5 Exp2 Control D | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-57 | Fig5 Exp2 Control E | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-58 | Fig5 Exp2 Control F | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-59 | Fig5 Exp2 Treated A | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-60 | Fig5 Exp2 Treated B | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-61 | Fig5 Exp2 Treated C | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-62 | Fig5 Exp2 Treated D | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-63 | Fig5 Exp2 Treated E | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-64 | Fig5 Exp2 Treated F | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-65 | Fig5 Exp2 Treated G | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-66 | Fig5 Exp3 Control A | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-67 | Fig5 Exp3 Control B | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-68 | Fig5 Exp3 Control C | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-69 | Fig5 Exp3 Control D | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-70 | Fig5 Exp3 Control E | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-71 | Fig5 Exp3 Control F | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-72 | Fig5 Exp3 Treated A | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-73 | Fig5 Exp3 Treated B | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-74 | Fig5 Exp3 Treated C | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-75 | Fig5 Exp3 Treated D | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-76 | Fig5 Exp3 Treated E | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-77 | Fig5 Exp3 Treated F | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | |||||
| OOC-250519KAM-78 | Exp1 CC01 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-79 | Exp1 CC02 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-80 | Exp1 CC03 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-81 | Exp1 CC04 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-82 | Exp1 CC05 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-83 | Exp1 TC01 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No Treatment, treated(TGF-B/control) | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-84 | Exp1 TC02 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No Treatment, treated(TGF-B/control) | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-85 | Exp1 TC03 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No Treatment, treated(TGF-B/control) | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-86 | Exp1 TC04 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No Treatment, treated(TGF-B/control) | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-87 | Exp1 TS01 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | SB-431542 | 10 | uM | https://www.tocris.com/products/sb-431542_1614 | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-88 | Exp1 TS02 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | SB-431542 | 10 | uM | https://www.tocris.com/products/sb-431542_1614 | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-89 | Exp1 TS03 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | SB-431542 | 10 | uM | https://www.tocris.com/products/sb-431542_1614 | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-90 | Exp1 TS04 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | SB-431542 | 10 | uM | https://www.tocris.com/products/sb-431542_1614 | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-91 | Exp1 TS05 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | SB-431542 | 10 | uM | https://www.tocris.com/products/sb-431542_1614 | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-92 | Exp1 TV01 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | VEGF | 0.05 | ug/ml | https://www.thermofisher.com/proteins/product/Human-VEGF-165-Recombinant-Protein/100-20-10UG | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-93 | Exp1 TV02 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | VEGF | 0.05 | ug/ml | https://www.thermofisher.com/proteins/product/Human-VEGF-165-Recombinant-Protein/100-20-10UG | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-94 | Exp1 TV03 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | VEGF | 0.05 | ug/ml | https://www.thermofisher.com/proteins/product/Human-VEGF-165-Recombinant-Protein/100-20-10UG | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-95 | Exp1 TV04 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | VEGF | 0.05 | ug/ml | https://www.thermofisher.com/proteins/product/Human-VEGF-165-Recombinant-Protein/100-20-10UG | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-96 | Exp1 TV05 | CEL-250519KAM-2; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | VEGF | 0.05 | ug/ml | https://www.thermofisher.com/proteins/product/Human-VEGF-165-Recombinant-Protein/100-20-10UG | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
| OOC-250519KAM-97 | Exp2 CC01 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-98 | Exp2 CC02 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx | |||
| OOC-250519KAM-99 | Exp2 CC03 | CEL-250519KAM-3; CEL-250519KAM-1 | Imaging | Vasculogenesis | Elena Cambria | P.KAM-250519-V2_EC_Myofibroblast_ExperimentalDesign.docx | Polydimethylsiloxane (PDMS) | See Protocol for full Media information | No treatment, control/control | P.KAM-250519-V1_EC_Myofibroblast_Treatment_Recovery.docx |
A
B
C
D
E
F
G
H
I
J
K
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
A
B
C
D
E
F
G
H
I
J
K
L
M
N
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
| UID | File_PrimaryData | Link_PrimaryData | Protocol | Scientist | Parent | SlideStain | Notes | AntibodyParent | Instrument | DataType | Checksum_PrimaryData | Magnification | Dataset |
| D.IMG-250519KAM-1 | Experiment 3_a-SMA_Controls_C1.oib | https://omero.mit.edu/webclient/img_detail/24866/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 6f6751c30d68ac2685a3fa9f82d65179 | 20x | Figure 2 | |
| D.IMG-250519KAM-2 | Experiment 3_a-SMA_Controls_C2.oib | https://omero.mit.edu/webclient/img_detail/24857/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 76112c54e3690b7db067ef9562098ce8 | 20x | Figure 2 | |
| D.IMG-250519KAM-3 | Experiment 3_a-SMA_Controls_C3.oib | https://omero.mit.edu/webclient/img_detail/24862/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | e727fd64620901de75ea350dcdbf3c7c | 20x | Figure 2 | |
| D.IMG-250519KAM-4 | Experiment 3_a-SMA_Treated_T1.oib | https://omero.mit.edu/webclient/img_detail/24852/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 88b705fc6d0c9f0bf72a317ec497327f | 20x | Figure 2 | |
| D.IMG-250519KAM-5 | Experiment 3_a-SMA_Treated_T2.oib | https://omero.mit.edu/webclient/img_detail/24868/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 5d431c2bea3e585222a59c7fc1c58f62 | 20x | Figure 2 | |
| D.IMG-250519KAM-6 | Experiments 1-2_a-SMA_Controls_C1_01.oib | https://omero.mit.edu/webclient/img_detail/24867/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 86da8499e301e94d5b4cba94d0906c2f | 20x | Figure 2 | |
| D.IMG-250519KAM-7 | Experiments 1-2_a-SMA_Treated_T1_01.oib | https://omero.mit.edu/webclient/img_detail/24855/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 107402fbb4f924331c0bd4108d9f2cdb | 20x | Figure 2 | |
| D.IMG-250519KAM-8 | Experiments 1-2_a-SMA_Treated_T2_01.oib | https://omero.mit.edu/webclient/img_detail/24856/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 7d4b74aba0e6d340a5fcf0125d44ea22 | 20x | Figure 2 | |
| D.IMG-250519KAM-9 | Experiments 1-2_a-SMA_Treated_T3_01.oib | https://omero.mit.edu/webclient/img_detail/24858/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | b7e86cfbe3d9ace1a4c49260e6a3eecd | 20x | Figure 2 | |
| D.IMG-250519KAM-10 | Experiments 1-2_collagen-actin-fibronectin_Controls_C1_01.oib | https://omero.mit.edu/webclient/img_detail/24861/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | ef9d8d73051c4edb7202b6cf5aacc09d | 20x | Figure 2 | |
| D.IMG-250519KAM-11 | Experiments 1-2_collagen-actin-fibronectin_Controls_C2_01.oib | https://omero.mit.edu/webclient/img_detail/24865/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | fb097b506be750f206db9426d44235db | 20x | Figure 2 | |
| D.IMG-250519KAM-12 | Experiments 1-2_collagen-actin-fibronectin_Controls_C3_01.oib | https://omero.mit.edu/webclient/img_detail/24860/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 7bb06399325e5d2b80027d9374d8c9aa | 20x | Figure 2 | |
| D.IMG-250519KAM-13 | Experiments 1-2_collagen-actin-fibronectin_Controls_C4_01.oib | https://omero.mit.edu/webclient/img_detail/24859/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-3 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 874c6745f936169dd5b26eb8bfc3d2de | 20x | Figure 2 | |
| D.IMG-250519KAM-14 | Experiments 1-2_collagen-actin-fibronectin_Treated_T1_01.oib | https://omero.mit.edu/webclient/img_detail/24863/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | af6fd08a23d0397dae73ff93be17d706 | 20x | Figure 2 | |
| D.IMG-250519KAM-15 | Experiments 1-2_collagen-actin-fibronectin_Treated_T2_01.oib | https://omero.mit.edu/webclient/img_detail/24864/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | a9e0ef4d7f9c5310819a690974ba303f | 20x | Figure 2 | |
| D.IMG-250519KAM-16 | Experiments 1-2_collagen-actin-fibronectin_Treated_T3_01.oib | https://omero.mit.edu/webclient/img_detail/24854/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 5673d6dc481ee122ffcc36b101b0878a | 20x | Figure 2 | |
| D.IMG-250519KAM-17 | Experiments 1-2_collagen-actin-fibronectin_Treated_T4_01.oib | https://omero.mit.edu/webclient/img_detail/24851/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 56d93b7218711e47dad23b8f40bac2b5 | 20x | Figure 2 | |
| D.IMG-250519KAM-18 | Experiments 1-2_collagen-actin-fibronectin_Treated_T5_01.oib | https://omero.mit.edu/webclient/img_detail/24853/?dataset=1901 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | CEL-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 7c09153f04df7e953f2d53c6c4a0d175 | 20x | Figure 2 | |
| D.IMG-250519KAM-19 | Exp 1_Control01_aSMA_Fact_DAPI.oib | https://omero.mit.edu/webclient/img_detail/24890/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-1 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | a1f225c639ef270aae61eec1189dd980 | 20x | Figure 3 | |
| D.IMG-250519KAM-20 | Exp 1_Control01_Fibro_Col.oib | https://omero.mit.edu/webclient/img_detail/24881/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-1 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | de41844d14bfd4b2c4f7073674078dfd | 20x | Figure 3 | |
| D.IMG-250519KAM-21 | Exp 1_Control02_aSMA_Fact_DAPI.oib | https://omero.mit.edu/webclient/img_detail/24889/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-2 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | f76827806bf1bc1228215c4e857d0b1c | 20x | Figure 3 | |
| D.IMG-250519KAM-22 | Exp 1_Control02_Fibro_Col.oib | https://omero.mit.edu/webclient/img_detail/24896/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-2 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | b8be8ffe441bdd0ff9c98327f95d32e3 | 20x | Figure 3 | |
| D.IMG-250519KAM-23 | Exp 1_Treated01_aSMA_Fact_DAPI.oib | https://omero.mit.edu/webclient/img_detail/24910/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-3 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 4218c09898bc7c6a003b0849a44e4ae9 | 20x | Figure 3 | |
| D.IMG-250519KAM-24 | Exp 1_Treated01_Fibro_Col.oib | https://omero.mit.edu/webclient/img_detail/24882/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-3 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 8f97d40880f9e54411cef66318a23a7f | 20x | Figure 3 | |
| D.IMG-250519KAM-25 | Exp 1_Treated02_aSMA_Fact_DAPI.oib | https://omero.mit.edu/webclient/img_detail/24915/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-4 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 448898edbfe19c457c3f9109dc2d5369 | 20x | Figure 3 | |
| D.IMG-250519KAM-26 | Exp 1_Treated02_Fibro_Col.oib | https://omero.mit.edu/webclient/img_detail/24917/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-4 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | ac656910404eb8283c61bab97033423b | 20x | Figure 3 | |
| D.IMG-250519KAM-27 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24873/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-5 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | ed44398b20a012b8f0a212d18cacdddf | 20x | Figure 3 | |
| D.IMG-250519KAM-28 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24878/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-5 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 782bad48521f178a9256df5a32694085 | 20x | Figure 3 | |
| D.IMG-250519KAM-29 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24872/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-5 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | f59ae95a100f7ee62844dac0cac0e246 | 20x | Figure 3 | |
| D.IMG-250519KAM-30 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24894/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-6 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 2e7dd90865a21018f47fa300ffe220fe | 20x | Figure 3 | |
| D.IMG-250519KAM-31 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24923/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-6 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | a75f9e79b23c6b39addcf183f0e3c902 | 20x | Figure 3 | |
| D.IMG-250519KAM-32 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24892/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-6 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 0b32c4030a0395e40273e7066c3f2343 | 20x | Figure 3 | |
| D.IMG-250519KAM-33 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24918/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-7 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | deff0416a1f0d0719624970a604e07e7 | 20x | Figure 3 | |
| D.IMG-250519KAM-34 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24885/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-7 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 9264a9a05750c13e533a15183c54d92c | 20x | Figure 3 | |
| D.IMG-250519KAM-35 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24912/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-7 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 3309fa9592ecb279f1db611f719b8f41 | 20x | Figure 3 | |
| D.IMG-250519KAM-36 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24871/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-8 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 64c4f1a2926a914f5f3ccec21ca0b8b7 | 20x | Figure 3 | |
| D.IMG-250519KAM-37 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24869/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-8 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | edebd4786c1408a175a08974f8ba9d02 | 20x | Figure 3 | |
| D.IMG-250519KAM-38 | Exp 2_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24870/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-8 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 6e923cd38b918ec59e235ec47f7597e9 | 20x | Figure 3 | |
| D.IMG-250519KAM-39 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24921/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-9 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | d8c7a59ee2c830bcdd2e23b891068448 | 20x | Figure 3 | |
| D.IMG-250519KAM-40 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24895/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-9 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 7af549dc87fa9ffbddb13109a614079b | 20x | Figure 3 | |
| D.IMG-250519KAM-41 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24916/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-9 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | c8a582f2cce083961b75933d2114b69b | 20x | Figure 3 | |
| D.IMG-250519KAM-42 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24901/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-10 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 96eb00e116144b523e1065f5146a6c2f | 20x | Figure 3 | |
| D.IMG-250519KAM-43 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24899/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-10 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | f19053f3ae36d6b7b4ea589aa3dfa3a4 | 20x | Figure 3 | |
| D.IMG-250519KAM-44 | Exp 2_S1_RedActin_FarRedaSMA_C_S1_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24900/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-10 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 0d4113afafb7af5ee572f513232caa39 | 20x | Figure 3 | |
| D.IMG-250519KAM-45 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24874/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-11 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 260397882725ebff7b1d39dae436ce7a | 20x | Figure 3 | |
| D.IMG-250519KAM-46 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24879/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-11 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 2cc0bfb76aed3fe064831509bf0732e5 | 20x | Figure 3 | |
| D.IMG-250519KAM-47 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24875/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-11 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 6e5e13429c7a86f218b92f232aed0e63 | 20x | Figure 3 | |
| D.IMG-250519KAM-48 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24883/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-12 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 9e1ebf5b1a095fe664e5ef4b49eaba9f | 20x | Figure 3 | |
| D.IMG-250519KAM-49 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24911/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-12 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 6c25eb60c04a04dbfe97ff61e01b7ffe | 20x | Figure 3 | |
| D.IMG-250519KAM-50 | Exp 2_S1_RedActin_FarRedaSMA_T_S1_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24884/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-12 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 440432e2ecfc7af24d5011634a36b90a | 20x | Figure 3 | |
| D.IMG-250519KAM-51 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24898/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-13 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 8162dbe3222c30ce6ede6fb023e89b65 | 20x | Figure 3 | |
| D.IMG-250519KAM-52 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24897/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-13 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 7178b0db124a5a0d3d6f4c48e0cb5b02 | 20x | Figure 3 | |
| D.IMG-250519KAM-53 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24924/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-13 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 668c6bc52c6a06d86a2867c58c569ae2 | 20x | Figure 3 | |
| D.IMG-250519KAM-54 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24876/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-14 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 7d402438e5913cc609b1eca45aec4888 | 20x | Figure 3 | |
| D.IMG-250519KAM-55 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24880/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-14 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 2c0824fe2f38bc4559071bed1936d8aa | 20x | Figure 3 | |
| D.IMG-250519KAM-56 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_C_ECM_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24877/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-14 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 3ea896c5438050a0cf3b73410e9e42a9 | 20x | Figure 3 | |
| D.IMG-250519KAM-57 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24904/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-15 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | dc7c2c63f99a3bbee11e2d57a289e89e | 20x | Figure 3 | |
| D.IMG-250519KAM-58 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24905/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-15 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 71c4e6f28c4975da795cb0c9135ea756 | 20x | Figure 3 | |
| D.IMG-250519KAM-59 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24906/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-15 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 138297da3e1ddaeebb6f9a93c5877dd6 | 20x | Figure 3 | |
| D.IMG-250519KAM-60 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24920/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-16 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | baef7f54b536e7e42d0ab5e5a9ce8283 | 20x | Figure 3 | |
| D.IMG-250519KAM-61 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24886/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-16 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 3259eef7d2ed772b7e8fc7da448811c7 | 20x | Figure 3 | |
| D.IMG-250519KAM-62 | Exp 3_ECM_RedActin_GreenColl1_FarRedFN_T_ECM_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24913/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-16 | Collagen I, Fibronectin, F-Actin, DAPI | AB-250519KAM-2; AB-250519KAM-3 | Olympus FLUOVIEW FV1200 | oib | 4d53467d7f9b93725e59a716987ad538 | 20x | Figure 3 | |
| D.IMG-250519KAM-63 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24909/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-17 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 38682a7c4b3ac2f8bdc32c37ed5a5bcc | 20x | Figure 3 | |
| D.IMG-250519KAM-64 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24907/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-17 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | a620d41175b0ad557a45f3fb75b48432 | 20x | Figure 3 | |
| D.IMG-250519KAM-65 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24908/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-17 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | c9f5f013e59654df4c3c71598b972baf | 20x | Figure 3 | |
| D.IMG-250519KAM-66 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24888/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-18 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | d6a51d6568214d945198dcc6bdc4ab82 | 20x | Figure 3 | |
| D.IMG-250519KAM-67 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24914/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-18 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 596c65c09b1c10fde24b3336969ece52 | 20x | Figure 3 | |
| D.IMG-250519KAM-68 | Exp 3_S1_RedActin_FarRedaSMA_C_S1_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24887/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-18 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 53c14b88616154c9bf1ad4f4795e35f7 | 20x | Figure 3 | |
| D.IMG-250519KAM-69 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24893/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-19 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 52b20b051f579fc59ec5cee0c274a2b7 | 20x | Figure 3 | |
| D.IMG-250519KAM-70 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_001_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24922/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-19 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | cb5dc015123f11b7c3813204da2f2e06 | 20x | Figure 3 | |
| D.IMG-250519KAM-71 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_001_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24891/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-19 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | b72a7986b34f2d2d5e1c4ed2c0a43a90 | 20x | Figure 3 | |
| D.IMG-250519KAM-72 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_002_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/24919/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-20 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 6af7c7f29dbc4e83e7724cbd22a34ded | 20x | Figure 3 | |
| D.IMG-250519KAM-73 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_002_ROI2_01.oib | https://omero.mit.edu/webclient/img_detail/24902/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-20 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 1618d11c628d44fa97cfc6d99ec2c328 | 20x | Figure 3 | |
| D.IMG-250519KAM-74 | Exp 3_S1_RedActin_FarRedaSMA_T_S1_002_ROI3_01.oib | https://omero.mit.edu/webclient/img_detail/24903/?dataset=1902 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-20 | a-SMA, F-actin, DAPI | AB-250519KAM-1 | Olympus FLUOVIEW FV1200 | oib | 7d98e33e66969a222373489ba4f694d0 | 20x | Figure 3 | |
| D.IMG-250519KAM-75 | Exp1_angiogenesis_images_fullVL--treated-A.oib | https://omero.mit.edu/webclient/img_detail/24935/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-21 | Olympus FV1000 | oib | d903aa56d0f20fa71c4e8f4f86cc549d | Figure 4 | ||||
| D.IMG-250519KAM-76 | Exp1_angiogenesis_images_fullVL-control-A.oib | https://omero.mit.edu/webclient/img_detail/24929/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-22 | Olympus FV1000 | oib | f9816cfd581eb72cf31163631570791f | Figure 4 | ||||
| D.IMG-250519KAM-77 | Exp1_angiogenesis_images_fullVL-control-B.oib | https://omero.mit.edu/webclient/img_detail/24942/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-23 | Olympus FV1000 | oib | d2728a0c487d2be15a54871bfc604ef5 | Figure 4 | ||||
| D.IMG-250519KAM-78 | Exp1_angiogenesis_images_fullVL-control-C.oib | https://omero.mit.edu/webclient/img_detail/24928/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-24 | Olympus FV1000 | oib | 6f938fe4b72e22f6258ca3a8b0155c13 | Figure 4 | ||||
| D.IMG-250519KAM-79 | Exp1_angiogenesis_images_fullVL-control-D.oib | https://omero.mit.edu/webclient/img_detail/24944/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-25 | Olympus FV1000 | oib | b97faf7b20fb7e2255bb27538dc283f0 | Figure 4 | ||||
| D.IMG-250519KAM-80 | Exp1_angiogenesis_images_fullVL-treated-B.oib | https://omero.mit.edu/webclient/img_detail/24945/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-26 | Olympus FV1000 | oib | cbab6845e0cfe75659bc1ebab2054383 | Figure 4 | ||||
| D.IMG-250519KAM-81 | Exp1_angiogenesis_images_fullVL-treated-C.oib | https://omero.mit.edu/webclient/img_detail/24930/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-27 | ` | Olympus FV1000 | oib | e7ac6ea3ca73fffab5cfaf3014298153 | Figure 4 | |||
| D.IMG-250519KAM-82 | Exp1_angiogenesis_images_fullVL-treated-D.oib | https://omero.mit.edu/webclient/img_detail/24931/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-28 | Olympus FV1000 | oib | 6ed037d2bf4130aec38ee89a26b391c6 | Figure 4 | ||||
| D.IMG-250519KAM-83 | Exp2_angiogenesis_images_control-fullVL-A.oib | https://omero.mit.edu/webclient/img_detail/24936/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-29 | Olympus FV1000 | oib | 2f19f9ed2183475233726c961e1650af | Figure 4 | ||||
| D.IMG-250519KAM-84 | Exp2_angiogenesis_images_control-fullVL-B.oib | https://omero.mit.edu/webclient/img_detail/24947/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-30 | Olympus FV1000 | oib | 0d19a74657bf7cfbafad561a14574b55 | Figure 4 | ||||
| D.IMG-250519KAM-85 | Exp2_angiogenesis_images_control-fullVL-C.oib | https://omero.mit.edu/webclient/img_detail/24933/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-31 | Olympus FV1000 | oib | 56b05aee588d13bdc487c65743b7a811 | Figure 4 | ||||
| D.IMG-250519KAM-86 | Exp2_angiogenesis_images_control-fullVL-D.oib | https://omero.mit.edu/webclient/img_detail/24926/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-32 | Olympus FV1000 | oib | 996d0db08a8500ac5e60fbd2ae5b1673 | Figure 4 | ||||
| D.IMG-250519KAM-87 | Exp2_angiogenesis_images_treated-fullVL-A.oib | https://omero.mit.edu/webclient/img_detail/24932/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-33 | Olympus FV1000 | oib | d7421d9ba1ddaf2f345baacb43b88f9a | Figure 4 | ||||
| D.IMG-250519KAM-88 | Exp2_angiogenesis_images_treated-fullVL-B.oib | https://omero.mit.edu/webclient/img_detail/24946/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-34 | Olympus FV1000 | oib | 2f0b89897719839fca8ae9024023f1d7 | Figure 4 | ||||
| D.IMG-250519KAM-89 | Exp2_angiogenesis_images_treated-fullVL-C.oib | https://omero.mit.edu/webclient/img_detail/24937/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-35 | Olympus FV1000 | oib | 962335a393fc0b1c1d802b3f3737f208 | Figure 4 | ||||
| D.IMG-250519KAM-90 | Exp2_angiogenesis_images_treated-fullVL-D.oib | https://omero.mit.edu/webclient/img_detail/24925/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-36 | Olympus FV1000 | oib | 25960167e840e1178febb0bc914919a8 | Figure 4 | ||||
| D.IMG-250519KAM-91 | Exp3_angiogenesis_images_Control-A.oib | https://omero.mit.edu/webclient/img_detail/24940/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-37 | Olympus FV1000 | oib | 96720549157d89a6d5bf1d4d28039339 | Figure 4 | ||||
| D.IMG-250519KAM-92 | Exp3_angiogenesis_images_Control-B.oib | https://omero.mit.edu/webclient/img_detail/24927/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-38 | Olympus FV1000 | oib | e6fb57fd0ada6de0691ba7c849537769 | Figure 4 | ||||
| D.IMG-250519KAM-93 | Exp3_angiogenesis_images_Control-C.oib | https://omero.mit.edu/webclient/img_detail/24943/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-39 | Olympus FV1000 | oib | 8af9041f6c352a8c768bd6f060c4d3ef | Figure 4 | ||||
| D.IMG-250519KAM-94 | Exp3_angiogenesis_images_Control-D.oib | https://omero.mit.edu/webclient/img_detail/24938/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-40 | Olympus FV1000 | oib | cd3e4dda4b4cd9721fa3106034d74a53 | Figure 4 | ||||
| D.IMG-250519KAM-95 | Exp3_angiogenesis_images_Treated-A.oib | https://omero.mit.edu/webclient/img_detail/24939/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-41 | Olympus FV1000 | oib | 1815943dab0deb3c273375e00396a00d | Figure 4 | ||||
| D.IMG-250519KAM-96 | Exp3_angiogenesis_images_Treated-B.oib | https://omero.mit.edu/webclient/img_detail/24948/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-42 | Olympus FV1000 | oib | 446ed217a0001197bf808deec8e26207 | Figure 4 | ||||
| D.IMG-250519KAM-97 | Exp3_angiogenesis_images_Treated-C.oib | https://omero.mit.edu/webclient/img_detail/24934/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-43 | Olympus FV1000 | oib | bc43e9550a0c45344bedf598e58aa4db | Figure 4 | ||||
| D.IMG-250519KAM-98 | Exp3_angiogenesis_images_Treated-D.oib | https://omero.mit.edu/webclient/img_detail/24941/?dataset=1903 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-44 | Olympus FV1000 | oib | cea4d73d689bf3be4060a75db41f09fb | Figure 4 | ||||
| D.IMG-250519KAM-99 | Exp1_Controls_C001_ROI1_01.oib | https://omero.mit.edu/webclient/img_detail/25073/?dataset=1904 | P.KAM-250519-V2_EC_Myofibroblast_Imaging.docx | Elena Cambria | OOC-250519KAM-45 | Olympus FV1000 | oib | 7ee2351c071a8e1e51cb61d62ca297b0 | Figure 5 |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | Name | Protocol | Scientist | Parent | Type | Notes | |||
| RNA-250520KAM-1 | yellow-day10-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-3 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-2 | yellow-day10-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-2 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-3 | white-day10-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-3 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-4 | white-day10-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-2 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-5 | red-day10-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-3 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-6 | red-day10-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | CEL-250519KAM-2 | Total RNA | RNA from 3 plates from 3 independent experiments (yellow, white, red), technical duplicates | |||
| RNA-250520KAM-7 | blue-3D-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-250520KAM-1 | Total RNA | RNA pooled from 6 devices from each group, technical duplicates | |||
| RNA-250520KAM-8 | blue-3D-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-250520KAM-2 | Total RNA | RNA pooled from 6 devices from each group, technical duplicates | |||
| RNA-251118KAM-1 | Exp2-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-251118KAM-81 | Total RNA | RNA pooled from 12 devices from each group, technical duplicates | |||
| RNA-251118KAM-2 | Exp2-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-251118KAM-82 | Total RNA | RNA pooled from 12 devices from each group, technical duplicates | |||
| RNA-251118KAM-3 | Exp3-ctrl | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-251118KAM-83 | Total RNA | RNA pooled from 12 devices from each group, technical duplicates | |||
| RNA-251118KAM-4 | Exp3-treated | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | Elena Cambria | OOC-251118KAM-84 | Total RNA | RNA pooled from 12 devices from each group, technical duplicates | |||
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | Scientist | Type | Parent | Protocol | ExtractionKit | Software | SynthesisKit | PrimerSource | PrimerSequences | Instrument | NormalizationGene | QuantificationMethod | GeneTargets |
| D.PCR-250520KAM-1 | 2D_PCR_day10_analysis.xlsx | https://zenodo.org/records/15475937/files/2D_PCR_day10_analysis.xlsx?download=1&preview=1 | 9688cfcd122c9104783cc8030b2f1223 | Elena Cambria | Real-time RT-PCR | RNA-250520KAM-1; RNA-250520KAM-2; RNA-250520KAM-3; RNA-250520KAM-4; RNA-250520KAM-5; RNA-250520KAM-6 | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | RNeasy Mini Kit (Qiagen) | Applied Biosystems software | SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher) | Integrated DNA Technologies: SEE PROTOCOL | Massachusetts General Hospital Primer Bank: SEE PROTOCOL | Applied Biosystems 7300 Fast Real-Time PCR System | h36b4 | 2-delta delta Ct method | ACTA2, COL1A1, FN1 |
| D.PCR-250520KAM-2 | 3D_PCR_day10+7.xlsx | https://zenodo.org/records/15475937/files/3D_PCR_day10+7.xlsx?download=1&preview=1 | d332faaf9b233596ff5309894524b80b | Elena Cambria | Real-time RT-PCR | RNA-250520KAM-7; RNA-250520KAM-8 | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | RNeasy Mini Kit (Qiagen) | Applied Biosystems software | SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher) | Integrated DNA Technologies: SEE PROTOCOL | Massachusetts General Hospital Primer Bank: SEE PROTOCOL | Applied Biosystems 7300 Fast Real-Time PCR System | h36b4 | 2-delta delta Ct method | ACTA2, COL1A1, FN1 |
| D.PCR-251118KAM-1 | Exp1_3D_qPCR_day10+7_analysis.xlsx | https://zenodo.org/records/15475937/files/Exp1_3D_qPCR_day10+7_analysis.xlsx?download=1&preview=1 | bdfab64f790a1729f719be68fb40f3c9 | Elena Cambria | Real-time RT-PCR | RNA-250520KAM-7; RNA-250520KAM-8 | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | RNeasy Mini Kit (Qiagen) | Applied Biosystems software | SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher) | Integrated DNA Technologies: SEE PROTOCOL | Massachusetts General Hospital Primer Bank: SEE PROTOCOL | Applied Biosystems 7300 Fast Real-Time PCR System | h36b4 | 2-delta delta Ct method | ACTA2, COL1A1, FN1 |
| D.PCR-251118KAM-2 | Exp2_3D_qPCR_d10+7_analysis.xlsx | https://zenodo.org/records/15475937/files/Exp2_3D_qPCR_d10+7_analysis.xlsx?download=1&preview=1 | 23b10468955bf6a6c24871f078c713c0 | Elena Cambria | Real-time RT-PCR | RNA-251118KAM-1; RNA-251118KAM-2 | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | RNeasy Mini Kit (Qiagen) | Applied Biosystems software | SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher) | Integrated DNA Technologies: SEE PROTOCOL | Massachusetts General Hospital Primer Bank: SEE PROTOCOL | Applied Biosystems 7300 Fast Real-Time PCR System | h36b4 | 2-delta delta Ct method | ACTA2, COL1A1, FN1 |
| D.PCR-251118KAM-3 | Exp3_3D_qPCR_d10+7_analysis.xlsx | https://zenodo.org/records/15475937/files/Exp3_3D_qPCR_d10+7_analysis.xlsx?download=1&preview=1 | f4e0dfde96c7a1637e24b6423bd7eb9e | Elena Cambria | Real-time RT-PCR | RNA-251118KAM-3; RNA-251118KAM-4 | P.KAM-250519-V2_EC_Myofibroblast_RT-PCR.docx | RNeasy Mini Kit (Qiagen) | Applied Biosystems software | SuperScript III First-Strand Synthesis SuperMix (Thermo Fisher) | Integrated DNA Technologies: SEE PROTOCOL | Massachusetts General Hospital Primer Bank: SEE PROTOCOL | Applied Biosystems 7300 Fast Real-Time PCR System | h36b4 | 2-delta delta Ct method | ACTA2, COL1A1, FN1 |
A
B
C
D
E
F
G
H
I
J
K
L
M
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | Protocol | Parent | Scientist | Panel | Kit | KitVendor | Instrument | Timepoints | Analyte |
| D.LMX-250520KAM-1 | Multiplex_cytokine_assay_analysis.xlsx | https://zenodo.org/records/15475937/files/Multiplex_cytokine_assay_analysis.xlsx?download=1&preview=1 | b813ccb29be4d6d86daccf804aef24d8 | P.KAM-250519-V2_EC_Myofibroblast_CytokineELISA.docx | OOC-250520KAM-3; OOC-250520KAM-4; OOC-250520KAM-5; OOC-250520KAM-6 | Elena Cambria | Human cytokine/chemokine magnetic bead panel | HCYTMAG-60K0PX30 | Millipore Sigma | Luminex Magpix system | Pooled media, collected across 6 devices per group, collected daily across 7 days | Eotaxin, G-CSF, GM-CSF, IFN-a2, IFN-ga, IL-10, IL-12P40, IL-12P70, IL-13, IL-15, IL-17A, IL-1RA, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IP-10, MCP-1, MIP-1a, MIP-1b, RANTES, TNFa, TNFb, VEGF |
| D.LMX-251118KAM-1 | Cytokine_assay_analysis.xlsx | https://zenodo.org/records/15475937/files/Cytokine_assay_analysis.xlsx?download=1&preview=1 | e3056fff3b3fa77e001a8390e2016b8d | P.KAM-250519-V2_EC_Myofibroblast_CytokineELISA.docx | OOC-250520KAM-3; OOC-250520KAM-4; OOC-250520KAM-5; OOC-250520KAM-6 | Elena Cambria | Human Cytokine/Chemokine Panel A 48-Plex Discovery Assay and a TGFB 3-Plex Discovery Assay Multi Species Array. | Eve Technologies | Pooled media, collected across 6 devices per group, collected daily across 7 days | |||
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | Protocol | Parent | Scientist | MeasurementTechnique | Analyte_Vendor | Analyte | Analyte_Catalog# | AnalyteProcedure | Plate | Plate_Vendor | Detector | Detector_Vendor | Instrument |
| D.ELSA-250520KAM-1 | TGFb1_ELISA_analysis.xlsx | https://zenodo.org/records/15475937/files/TGFb1_ELISA_analysis.xlsx?download=1&preview=1 | a25e41efb7069a22a0a2790534e1a74c | P.KAM-250519-V1_EC_Myofibroblast_CytokineELISA.docx | OOC-250520KAM-3; OOC-250520KAM-4; OOC-250520KAM-5; OOC-250520KAM-6 | Elena Cambria | Colorimetric ELISA (450 nm) | R&D Systems | TGF-B1 | D8100C | Quantikine ELISA for TGF-β1; followed manufacturer protocol | 96-well ELISA Plate | R&D Systems | SpectraMax i3x | Molecular Devices | SpectraMax i3x Microplate Reader |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| UID | File_PrimaryData | Link_PrimaryData | Checksum_PrimaryData | Software | Scientist | Parent | Protocol | ||
| A.IMG-250520KAM-1 | 2D_immunofluorescence_day10_analysis.xlsx | https://zenodo.org/records/15475937/files/2D_immunofluorescence_day10_analysis.xlsx?download=1&preview=1 | 13b0d7ccafc3b25cf4df985a10310985 | ImageJ | Elena Cambria | D.IMG-250519KAM-1; D.IMG-250519KAM-2; D.IMG-250519KAM-3; D.IMG-250519KAM-4; D.IMG-250519KAM-5; D.IMG-250519KAM-6; D.IMG-250519KAM-7; D.IMG-250519KAM-8; D.IMG-250519KAM-9; D.IMG-250519KAM-10; D.IMG-250519KAM-11; D.IMG-250519KAM-12; D.IMG-250519KAM-13; D.IMG-250519KAM-14; D.IMG-250519KAM-15; D.IMG-250519KAM-16; D.IMG-250519KAM-17; D.IMG-250519KAM-18 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-2 | 3D_immunofluorescence_day10+7_analysis.xlsx | https://zenodo.org/records/15475937/files/3D_immunofluorescence_day10+7_analysis.xlsx?download=1&preview=1 | 2dbedce53a33eac17acfbe70c9e371fc | ImageJ | Elena Cambria | D.IMG-250519KAM-19; D.IMG-250519KAM-20; D.IMG-250519KAM-21; D.IMG-250519KAM-22; D.IMG-250519KAM-23; D.IMG-250519KAM-24; D.IMG-250519KAM-25; D.IMG-250519KAM-26; D.IMG-250519KAM-27; D.IMG-250519KAM-28; D.IMG-250519KAM-29; D.IMG-250519KAM-30; D.IMG-250519KAM-31; D.IMG-250519KAM-32; D.IMG-250519KAM-33; D.IMG-250519KAM-34; D.IMG-250519KAM-35; D.IMG-250519KAM-36; D.IMG-250519KAM-37; D.IMG-250519KAM-38; D.IMG-250519KAM-39; D.IMG-250519KAM-40; D.IMG-250519KAM-41; D.IMG-250519KAM-42; D.IMG-250519KAM-43; D.IMG-250519KAM-44; D.IMG-250519KAM-45; D.IMG-250519KAM-46; D.IMG-250519KAM-47; D.IMG-250519KAM-48; D.IMG-250519KAM-49; D.IMG-250519KAM-50; D.IMG-250519KAM-51; D.IMG-250519KAM-52; D.IMG-250519KAM-53; D.IMG-250519KAM-54; D.IMG-250519KAM-55; D.IMG-250519KAM-56; D.IMG-250519KAM-57; D.IMG-250519KAM-58; D.IMG-250519KAM-59; D.IMG-250519KAM-60; D.IMG-250519KAM-61; D.IMG-250519KAM-62; D.IMG-250519KAM-63; D.IMG-250519KAM-64; D.IMG-250519KAM-65; D.IMG-250519KAM-66; D.IMG-250519KAM-67; D.IMG-250519KAM-68; D.IMG-250519KAM-69; D.IMG-250519KAM-70; D.IMG-250519KAM-71; D.IMG-250519KAM-72; D.IMG-250519KAM-73; D.IMG-250519KAM-74 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-3 | Figure-4-Angiogenesis_analysis.xlsx | https://zenodo.org/records/15475937/Figure-4-Angiogenesis_analysis.xlsx?download=1&preview=1 | db52f11349bb9a7dc1e7dcc1dce48ab1 | ImageJ | Elena Cambria | D.IMG-250519KAM-75; D.IMG-250519KAM-76; D.IMG-250519KAM-77; D.IMG-250519KAM-78; D.IMG-250519KAM-79; D.IMG-250519KAM-80; D.IMG-250519KAM-81; D.IMG-250519KAM-82; D.IMG-250519KAM-83; D.IMG-250519KAM-84; D.IMG-250519KAM-85; D.IMG-250519KAM-86; D.IMG-250519KAM-87; D.IMG-250519KAM-88; D.IMG-250519KAM-89; D.IMG-250519KAM-90; D.IMG-250519KAM-91; D.IMG-250519KAM-92; D.IMG-250519KAM-93; D.IMG-250519KAM-94; D.IMG-250519KAM-95; D.IMG-250519KAM-96; D.IMG-250519KAM-97; D.IMG-250519KAM-98 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-4 | Figure-5-Morphology_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure-5-Morphology_analysis.xlsx?download=1&preview=1 | 1d43322e2ebefa10b454ea5f04571150 | ImageJ | Elena Cambria | D.IMG-250519KAM-99; D.IMG-250519KAM-100; D.IMG-250519KAM-101; D.IMG-250519KAM-102; D.IMG-250519KAM-103; D.IMG-250519KAM-104; D.IMG-250519KAM-105; D.IMG-250519KAM-106; D.IMG-250519KAM-107; D.IMG-250519KAM-108; D.IMG-250519KAM-109; D.IMG-250519KAM-110; D.IMG-250519KAM-111; D.IMG-250519KAM-112; D.IMG-250519KAM-113; D.IMG-250519KAM-114; D.IMG-250519KAM-115; D.IMG-250519KAM-116; D.IMG-250519KAM-117; D.IMG-250519KAM-118; D.IMG-250519KAM-119; D.IMG-250519KAM-120; D.IMG-250519KAM-121; D.IMG-250519KAM-122; D.IMG-250519KAM-123; D.IMG-250519KAM-124; D.IMG-250519KAM-125; D.IMG-250519KAM-126; D.IMG-250519KAM-127; D.IMG-250519KAM-128; D.IMG-250519KAM-129; D.IMG-250519KAM-130; D.IMG-250519KAM-131; D.IMG-250519KAM-132; D.IMG-250519KAM-133; D.IMG-250519KAM-134; D.IMG-250519KAM-135; D.IMG-250519KAM-136; D.IMG-250519KAM-137; D.IMG-250519KAM-138; D.IMG-250519KAM-139; D.IMG-250519KAM-140; D.IMG-250519KAM-141; D.IMG-250519KAM-142; D.IMG-250519KAM-143; D.IMG-250519KAM-144; D.IMG-250519KAM-145; D.IMG-250519KAM-146; D.IMG-250519KAM-147; D.IMG-250519KAM-148; D.IMG-250519KAM-149; D.IMG-250519KAM-150; D.IMG-250519KAM-151; D.IMG-250519KAM-152; D.IMG-250519KAM-153; D.IMG-250519KAM-154; D.IMG-250519KAM-155; D.IMG-250519KAM-156; D.IMG-250519KAM-157; D.IMG-250519KAM-158; D.IMG-250519KAM-159; D.IMG-250519KAM-160; D.IMG-250519KAM-161; D.IMG-250519KAM-162; D.IMG-250519KAM-163; D.IMG-250519KAM-164; D.IMG-250519KAM-165; D.IMG-250519KAM-166; D.IMG-250519KAM-167; D.IMG-250519KAM-168; D.IMG-250519KAM-169; D.IMG-250519KAM-170; D.IMG-250519KAM-171; D.IMG-250519KAM-172; D.IMG-250519KAM-173; D.IMG-250519KAM-174; D.IMG-250519KAM-175; D.IMG-250519KAM-176; D.IMG-250519KAM-177; D.IMG-250519KAM-178; D.IMG-250519KAM-179; D.IMG-250519KAM-180; D.IMG-250519KAM-181; D.IMG-250519KAM-182; D.IMG-250519KAM-183; D.IMG-250519KAM-184; D.IMG-250519KAM-185; D.IMG-250519KAM-186; D.IMG-250519KAM-187; D.IMG-250519KAM-188; D.IMG-250519KAM-189; D.IMG-250519KAM-190; D.IMG-250519KAM-191; D.IMG-250519KAM-192; D.IMG-250519KAM-193; D.IMG-250519KAM-194; D.IMG-250519KAM-195; D.IMG-250519KAM-196; D.IMG-250519KAM-197; D.IMG-250519KAM-198; D.IMG-250519KAM-199; D.IMG-250519KAM-200; D.IMG-250519KAM-201; D.IMG-250519KAM-202; D.IMG-250519KAM-203; D.IMG-250519KAM-204; D.IMG-250519KAM-205; D.IMG-250519KAM-206; D.IMG-250519KAM-207; D.IMG-250519KAM-208; D.IMG-250519KAM-209; D.IMG-250519KAM-210; D.IMG-250519KAM-211; D.IMG-250519KAM-212; D.IMG-250519KAM-213; D.IMG-250519KAM-214; D.IMG-250519KAM-215; D.IMG-250519KAM-216; D.IMG-250519KAM-217; D.IMG-250519KAM-218; D.IMG-250519KAM-219; D.IMG-250519KAM-220; D.IMG-250519KAM-221; D.IMG-250519KAM-222; D.IMG-250519KAM-223; D.IMG-250519KAM-224; D.IMG-250519KAM-225; D.IMG-250519KAM-226; D.IMG-250519KAM-227; D.IMG-250519KAM-228; D.IMG-250519KAM-229; D.IMG-250519KAM-230; D.IMG-250519KAM-231; D.IMG-250519KAM-232; D.IMG-250519KAM-233; D.IMG-250519KAM-234; D.IMG-250519KAM-235; D.IMG-250519KAM-236; D.IMG-250519KAM-237; D.IMG-250519KAM-238; D.IMG-250519KAM-239; D.IMG-250519KAM-240; D.IMG-250519KAM-241; D.IMG-250519KAM-242; D.IMG-250519KAM-243; D.IMG-250519KAM-244; D.IMG-250519KAM-245; D.IMG-250519KAM-246; D.IMG-250519KAM-247; D.IMG-250519KAM-248; D.IMG-250519KAM-249; D.IMG-250519KAM-250; D.IMG-250519KAM-251; D.IMG-250519KAM-252; D.IMG-250519KAM-253; D.IMG-250519KAM-254; D.IMG-250519KAM-255; D.IMG-250519KAM-256; D.IMG-250519KAM-257; D.IMG-250519KAM-258; D.IMG-250519KAM-259; D.IMG-250519KAM-260; D.IMG-250519KAM-261; D.IMG-250519KAM-262; D.IMG-250519KAM-263; D.IMG-250519KAM-264; D.IMG-250519KAM-265; D.IMG-250519KAM-266; D.IMG-250519KAM-267; D.IMG-250519KAM-268; D.IMG-250519KAM-269; D.IMG-250519KAM-270; D.IMG-250519KAM-271; D.IMG-250519KAM-272; D.IMG-250519KAM-273; D.IMG-250519KAM-274; D.IMG-250519KAM-275; D.IMG-250519KAM-276; D.IMG-250519KAM-277; D.IMG-250519KAM-278; D.IMG-250519KAM-279; D.IMG-250519KAM-280; D.IMG-250519KAM-281; D.IMG-250519KAM-282; D.IMG-250519KAM-283; D.IMG-250519KAM-284; D.IMG-250519KAM-285; D.IMG-250519KAM-286; D.IMG-250519KAM-287; D.IMG-250519KAM-288; D.IMG-250519KAM-289; D.IMG-250519KAM-290 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-5 | All_data_permeability_analysis.xlsx | https://zenodo.org/records/15475937/All_data_permeability_analysis.xlsx?download=1&preview=1 | 6e55945d8625f51c316017151e7b7a17 | ImageJ | Elena Cambria | D.IMG-250519KAM-99; D.IMG-250519KAM-100; D.IMG-250519KAM-101; D.IMG-250519KAM-102; D.IMG-250519KAM-103; D.IMG-250519KAM-104; D.IMG-250519KAM-105; D.IMG-250519KAM-106; D.IMG-250519KAM-107; D.IMG-250519KAM-108; D.IMG-250519KAM-109; D.IMG-250519KAM-110; D.IMG-250519KAM-111; D.IMG-250519KAM-112; D.IMG-250519KAM-113; D.IMG-250519KAM-114; D.IMG-250519KAM-115; D.IMG-250519KAM-116; D.IMG-250519KAM-117; D.IMG-250519KAM-118; D.IMG-250519KAM-119; D.IMG-250519KAM-120; D.IMG-250519KAM-121; D.IMG-250519KAM-122; D.IMG-250519KAM-123; D.IMG-250519KAM-124; D.IMG-250519KAM-125; D.IMG-250519KAM-126; D.IMG-250519KAM-127; D.IMG-250519KAM-128; D.IMG-250519KAM-129; D.IMG-250519KAM-130; D.IMG-250519KAM-131; D.IMG-250519KAM-132; D.IMG-250519KAM-133; D.IMG-250519KAM-134; D.IMG-250519KAM-135; D.IMG-250519KAM-136; D.IMG-250519KAM-137; D.IMG-250519KAM-138; D.IMG-250519KAM-139; D.IMG-250519KAM-140; D.IMG-250519KAM-141; D.IMG-250519KAM-142; D.IMG-250519KAM-143; D.IMG-250519KAM-144; D.IMG-250519KAM-145; D.IMG-250519KAM-146; D.IMG-250519KAM-147; D.IMG-250519KAM-148; D.IMG-250519KAM-149; D.IMG-250519KAM-150; D.IMG-250519KAM-151; D.IMG-250519KAM-152; D.IMG-250519KAM-153; D.IMG-250519KAM-154; D.IMG-250519KAM-155; D.IMG-250519KAM-156; D.IMG-250519KAM-157; D.IMG-250519KAM-158; D.IMG-250519KAM-159; D.IMG-250519KAM-160; D.IMG-250519KAM-161; D.IMG-250519KAM-162; D.IMG-250519KAM-163; D.IMG-250519KAM-164; D.IMG-250519KAM-165; D.IMG-250519KAM-166; D.IMG-250519KAM-167; D.IMG-250519KAM-168; D.IMG-250519KAM-169; D.IMG-250519KAM-170; D.IMG-250519KAM-171; D.IMG-250519KAM-172; D.IMG-250519KAM-173; D.IMG-250519KAM-174; D.IMG-250519KAM-175; D.IMG-250519KAM-176; D.IMG-250519KAM-177; D.IMG-250519KAM-178; D.IMG-250519KAM-179; D.IMG-250519KAM-180; D.IMG-250519KAM-181; D.IMG-250519KAM-182; D.IMG-250519KAM-183; D.IMG-250519KAM-184; D.IMG-250519KAM-185; D.IMG-250519KAM-186; D.IMG-250519KAM-187; D.IMG-250519KAM-188; D.IMG-250519KAM-189; D.IMG-250519KAM-190; D.IMG-250519KAM-191; D.IMG-250519KAM-192; D.IMG-250519KAM-193; D.IMG-250519KAM-194; D.IMG-250519KAM-195; D.IMG-250519KAM-196; D.IMG-250519KAM-197; D.IMG-250519KAM-198; D.IMG-250519KAM-199; D.IMG-250519KAM-200; D.IMG-250519KAM-201; D.IMG-250519KAM-202; D.IMG-250519KAM-203; D.IMG-250519KAM-204; D.IMG-250519KAM-205; D.IMG-250519KAM-206; D.IMG-250519KAM-207; D.IMG-250519KAM-208; D.IMG-250519KAM-209; D.IMG-250519KAM-210; D.IMG-250519KAM-211; D.IMG-250519KAM-212; D.IMG-250519KAM-213; D.IMG-250519KAM-214; D.IMG-250519KAM-215; D.IMG-250519KAM-216; D.IMG-250519KAM-217; D.IMG-250519KAM-218; D.IMG-250519KAM-219; D.IMG-250519KAM-220; D.IMG-250519KAM-221; D.IMG-250519KAM-222; D.IMG-250519KAM-223; D.IMG-250519KAM-224; D.IMG-250519KAM-225; D.IMG-250519KAM-226; D.IMG-250519KAM-227; D.IMG-250519KAM-228; D.IMG-250519KAM-229; D.IMG-250519KAM-230; D.IMG-250519KAM-231; D.IMG-250519KAM-232; D.IMG-250519KAM-233; D.IMG-250519KAM-234; D.IMG-250519KAM-235; D.IMG-250519KAM-236; D.IMG-250519KAM-237; D.IMG-250519KAM-238; D.IMG-250519KAM-239; D.IMG-250519KAM-240; D.IMG-250519KAM-241; D.IMG-250519KAM-242; D.IMG-250519KAM-243; D.IMG-250519KAM-244; D.IMG-250519KAM-245; D.IMG-250519KAM-246; D.IMG-250519KAM-247; D.IMG-250519KAM-248; D.IMG-250519KAM-249; D.IMG-250519KAM-250; D.IMG-250519KAM-251; D.IMG-250519KAM-252; D.IMG-250519KAM-253; D.IMG-250519KAM-254; D.IMG-250519KAM-255; D.IMG-250519KAM-256; D.IMG-250519KAM-257; D.IMG-250519KAM-258; D.IMG-250519KAM-259; D.IMG-250519KAM-260; D.IMG-250519KAM-261; D.IMG-250519KAM-262; D.IMG-250519KAM-263; D.IMG-250519KAM-264; D.IMG-250519KAM-265; D.IMG-250519KAM-266; D.IMG-250519KAM-267; D.IMG-250519KAM-268; D.IMG-250519KAM-269; D.IMG-250519KAM-270; D.IMG-250519KAM-271; D.IMG-250519KAM-272; D.IMG-250519KAM-273; D.IMG-250519KAM-274; D.IMG-250519KAM-275; D.IMG-250519KAM-276; D.IMG-250519KAM-277; D.IMG-250519KAM-278; D.IMG-250519KAM-279; D.IMG-250519KAM-280; D.IMG-250519KAM-281; D.IMG-250519KAM-282; D.IMG-250519KAM-283; D.IMG-250519KAM-284; D.IMG-250519KAM-285; D.IMG-250519KAM-286; D.IMG-250519KAM-287; D.IMG-250519KAM-288; D.IMG-250519KAM-289; D.IMG-250519KAM-290 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-6 | All_data_drug_assay_permeability_analysis.xlsx | https://zenodo.org/records/15475937/files/All_data_drug_assay_permeability_analysis.xlsx?download=1&preview=1 | 7b4adcd926930fab290175aa1527229b | ImageJ | Elena Cambria | D.IMG-250519KAM-291; D.IMG-250519KAM-292; D.IMG-250519KAM-293; D.IMG-250519KAM-294; D.IMG-250519KAM-295; D.IMG-250519KAM-296; D.IMG-250519KAM-297; D.IMG-250519KAM-298; D.IMG-250519KAM-299; D.IMG-250519KAM-300; D.IMG-250519KAM-301; D.IMG-250519KAM-302; D.IMG-250519KAM-303; D.IMG-250519KAM-304; D.IMG-250519KAM-305; D.IMG-250519KAM-306; D.IMG-250519KAM-307; D.IMG-250519KAM-308; D.IMG-250519KAM-309; D.IMG-250519KAM-310; D.IMG-250519KAM-311; D.IMG-250519KAM-312; D.IMG-250519KAM-313; D.IMG-250519KAM-314; D.IMG-250519KAM-315; D.IMG-250519KAM-316; D.IMG-250519KAM-317; D.IMG-250519KAM-318; D.IMG-250519KAM-319; D.IMG-250519KAM-320; D.IMG-250519KAM-321; D.IMG-250519KAM-322; D.IMG-250519KAM-323; D.IMG-250519KAM-324; D.IMG-250519KAM-325; D.IMG-250519KAM-326; D.IMG-250519KAM-327; D.IMG-250519KAM-328; D.IMG-250519KAM-329; D.IMG-250519KAM-330; D.IMG-250519KAM-331; D.IMG-250519KAM-332; D.IMG-250519KAM-333; D.IMG-250519KAM-334; D.IMG-250519KAM-335; D.IMG-250519KAM-336; D.IMG-250519KAM-337; D.IMG-250519KAM-338; D.IMG-250519KAM-339; D.IMG-250519KAM-340; D.IMG-250519KAM-341; D.IMG-250519KAM-342; D.IMG-250519KAM-343; D.IMG-250519KAM-344; D.IMG-250519KAM-345; D.IMG-250519KAM-346; D.IMG-250519KAM-347; D.IMG-250519KAM-348; D.IMG-250519KAM-349; D.IMG-250519KAM-350; D.IMG-250519KAM-351; D.IMG-250519KAM-352; D.IMG-250519KAM-353; D.IMG-250519KAM-354; D.IMG-250519KAM-355; D.IMG-250519KAM-356; D.IMG-250519KAM-357; D.IMG-250519KAM-358; D.IMG-250519KAM-359; D.IMG-250519KAM-360; D.IMG-250519KAM-361; D.IMG-250519KAM-362; D.IMG-250519KAM-363; D.IMG-250519KAM-364; D.IMG-250519KAM-365; D.IMG-250519KAM-366; D.IMG-250519KAM-367; D.IMG-250519KAM-368; D.IMG-250519KAM-369; D.IMG-250519KAM-370; D.IMG-250519KAM-371; D.IMG-250519KAM-372; D.IMG-250519KAM-373; D.IMG-250519KAM-374; D.IMG-250519KAM-375; D.IMG-250519KAM-376; D.IMG-250519KAM-377; D.IMG-250519KAM-378; D.IMG-250519KAM-379; D.IMG-250519KAM-380; D.IMG-250519KAM-381; D.IMG-250519KAM-382; D.IMG-250519KAM-383; D.IMG-250519KAM-384; D.IMG-250519KAM-385; D.IMG-250519KAM-386; D.IMG-250519KAM-387; D.IMG-250519KAM-388; D.IMG-250519KAM-389; D.IMG-250519KAM-390; D.IMG-250519KAM-391; D.IMG-250519KAM-392; D.IMG-250519KAM-393; D.IMG-250519KAM-394; D.IMG-250519KAM-395; D.IMG-250519KAM-396; D.IMG-250519KAM-397; D.IMG-250519KAM-398; D.IMG-250519KAM-399; D.IMG-250519KAM-400; D.IMG-250519KAM-401; D.IMG-250519KAM-402; D.IMG-250519KAM-403; D.IMG-250519KAM-404; D.IMG-250519KAM-405; D.IMG-250519KAM-406; D.IMG-250519KAM-407; D.IMG-250519KAM-408; D.IMG-250519KAM-409; D.IMG-250519KAM-410; D.IMG-250519KAM-411; D.IMG-250519KAM-412; D.IMG-250519KAM-413; D.IMG-250519KAM-414; D.IMG-250519KAM-415; D.IMG-250519KAM-416; D.IMG-250519KAM-417; D.IMG-250519KAM-418; D.IMG-250519KAM-419; D.IMG-250519KAM-420; D.IMG-250519KAM-421; D.IMG-250519KAM-422; D.IMG-250519KAM-423; D.IMG-250519KAM-424; D.IMG-250519KAM-425; D.IMG-250519KAM-426; D.IMG-250519KAM-427; D.IMG-250519KAM-428; D.IMG-250519KAM-429; D.IMG-250519KAM-430; D.IMG-250519KAM-431; D.IMG-250519KAM-432; D.IMG-250519KAM-433; D.IMG-250519KAM-434; D.IMG-250519KAM-435; D.IMG-250519KAM-436; D.IMG-250519KAM-437; D.IMG-250519KAM-438; D.IMG-250519KAM-439; D.IMG-250519KAM-440; D.IMG-250519KAM-441; D.IMG-250519KAM-442; D.IMG-250519KAM-443; D.IMG-250519KAM-444; D.IMG-250519KAM-445; D.IMG-250519KAM-446; D.IMG-250519KAM-447; D.IMG-250519KAM-448; D.IMG-250519KAM-449; D.IMG-250519KAM-450; D.IMG-250519KAM-451; D.IMG-250519KAM-452; D.IMG-250519KAM-453; D.IMG-250519KAM-454; D.IMG-250519KAM-455; D.IMG-250519KAM-456; D.IMG-250519KAM-457; D.IMG-250519KAM-458; D.IMG-250519KAM-459; D.IMG-250519KAM-460; D.IMG-250519KAM-461; D.IMG-250519KAM-462; D.IMG-250519KAM-463; D.IMG-250519KAM-464; D.IMG-250519KAM-465; D.IMG-250519KAM-466; D.IMG-250519KAM-467; D.IMG-250519KAM-468; D.IMG-250519KAM-469; D.IMG-250519KAM-470; D.IMG-250519KAM-471; D.IMG-250519KAM-472; D.IMG-250519KAM-473; D.IMG-250519KAM-474; D.IMG-250519KAM-475; D.IMG-250519KAM-476; D.IMG-250519KAM-477; D.IMG-250519KAM-478; D.IMG-250519KAM-479; D.IMG-250519KAM-480; D.IMG-250519KAM-481; D.IMG-250519KAM-482; D.IMG-250519KAM-483; D.IMG-250519KAM-484; D.IMG-250519KAM-485; D.IMG-250519KAM-486; D.IMG-250519KAM-487; D.IMG-250519KAM-488; D.IMG-250519KAM-489; D.IMG-250519KAM-490; D.IMG-250519KAM-491; D.IMG-250519KAM-492; D.IMG-250519KAM-493; D.IMG-250519KAM-494; D.IMG-250519KAM-495; D.IMG-250519KAM-496; D.IMG-250519KAM-497; D.IMG-250519KAM-498; D.IMG-250519KAM-499; D.IMG-250519KAM-500; D.IMG-250519KAM-501; D.IMG-250519KAM-502; D.IMG-250519KAM-503; D.IMG-250519KAM-504; D.IMG-250519KAM-505; D.IMG-250519KAM-506; D.IMG-250519KAM-507; D.IMG-250519KAM-508; D.IMG-250519KAM-509; D.IMG-250519KAM-510; D.IMG-250519KAM-511; D.IMG-250519KAM-512; D.IMG-250519KAM-513; D.IMG-250519KAM-514; D.IMG-250519KAM-515; D.IMG-250519KAM-516; D.IMG-250519KAM-517; D.IMG-250519KAM-518; D.IMG-250519KAM-519; D.IMG-250519KAM-520; D.IMG-250519KAM-521; D.IMG-250519KAM-522; D.IMG-250519KAM-523; D.IMG-250519KAM-524; D.IMG-250519KAM-525; D.IMG-250519KAM-526; D.IMG-250519KAM-527; D.IMG-250519KAM-528; D.IMG-250519KAM-529; D.IMG-250519KAM-530; D.IMG-250519KAM-531; D.IMG-250519KAM-532; D.IMG-250519KAM-533; D.IMG-250519KAM-534; D.IMG-250519KAM-535; D.IMG-250519KAM-536; D.IMG-250519KAM-537; D.IMG-250519KAM-538; D.IMG-250519KAM-539; D.IMG-250519KAM-540; D.IMG-250519KAM-541; D.IMG-250519KAM-542; D.IMG-250519KAM-543; D.IMG-250519KAM-544; D.IMG-250519KAM-545; D.IMG-250519KAM-546; D.IMG-250519KAM-547; D.IMG-250519KAM-548; D.IMG-250519KAM-549; D.IMG-250519KAM-550; D.IMG-250519KAM-551; D.IMG-250519KAM-552; D.IMG-250519KAM-553; D.IMG-250519KAM-554; D.IMG-250519KAM-555; D.IMG-250519KAM-556; D.IMG-250519KAM-557; D.IMG-250519KAM-558; D.IMG-250519KAM-559; D.IMG-250519KAM-560; D.IMG-250519KAM-561; D.IMG-250519KAM-562; D.IMG-250519KAM-563; D.IMG-250519KAM-564; D.IMG-250519KAM-565; D.IMG-250519KAM-566; D.IMG-250519KAM-567; D.IMG-250519KAM-568; D.IMG-250519KAM-569; D.IMG-250519KAM-570; D.IMG-250519KAM-571; D.IMG-250519KAM-572; D.IMG-250519KAM-573; D.IMG-250519KAM-574; D.IMG-250519KAM-575; D.IMG-250519KAM-576; D.IMG-250519KAM-577; D.IMG-250519KAM-578; D.IMG-250519KAM-579; D.IMG-250519KAM-580; D.IMG-250519KAM-581; D.IMG-250519KAM-582; D.IMG-250519KAM-583; D.IMG-250519KAM-584; D.IMG-250519KAM-585; D.IMG-250519KAM-586; D.IMG-250519KAM-587; D.IMG-250519KAM-588; D.IMG-250519KAM-589; D.IMG-250519KAM-590; D.IMG-250519KAM-591; D.IMG-250519KAM-592; D.IMG-250519KAM-593; D.IMG-250519KAM-594; D.IMG-250519KAM-595; D.IMG-250519KAM-596 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-250520KAM-7 | Drug_assay_morphology_analysis.xlsx | https://zenodo.org/records/15475937/files/Drug_assay_morphology_analysis.xlsx?download=1&preview=1 | dd349d734189a71e157ce36b272da97f | ImageJ | Elena Cambria | D.IMG-250519KAM-291; D.IMG-250519KAM-292; D.IMG-250519KAM-293; D.IMG-250519KAM-294; D.IMG-250519KAM-295; D.IMG-250519KAM-296; D.IMG-250519KAM-297; D.IMG-250519KAM-298; D.IMG-250519KAM-299; D.IMG-250519KAM-300; D.IMG-250519KAM-301; D.IMG-250519KAM-302; D.IMG-250519KAM-303; D.IMG-250519KAM-304; D.IMG-250519KAM-305; D.IMG-250519KAM-306; D.IMG-250519KAM-307; D.IMG-250519KAM-308; D.IMG-250519KAM-309; D.IMG-250519KAM-310; D.IMG-250519KAM-311; D.IMG-250519KAM-312; D.IMG-250519KAM-313; D.IMG-250519KAM-314; D.IMG-250519KAM-315; D.IMG-250519KAM-316; D.IMG-250519KAM-317; D.IMG-250519KAM-318; D.IMG-250519KAM-319; D.IMG-250519KAM-320; D.IMG-250519KAM-321; D.IMG-250519KAM-322; D.IMG-250519KAM-323; D.IMG-250519KAM-324; D.IMG-250519KAM-325; D.IMG-250519KAM-326; D.IMG-250519KAM-327; D.IMG-250519KAM-328; D.IMG-250519KAM-329; D.IMG-250519KAM-330; D.IMG-250519KAM-331; D.IMG-250519KAM-332; D.IMG-250519KAM-333; D.IMG-250519KAM-334; D.IMG-250519KAM-335; D.IMG-250519KAM-336; D.IMG-250519KAM-337; D.IMG-250519KAM-338; D.IMG-250519KAM-339; D.IMG-250519KAM-340; D.IMG-250519KAM-341; D.IMG-250519KAM-342; D.IMG-250519KAM-343; D.IMG-250519KAM-344; D.IMG-250519KAM-345; D.IMG-250519KAM-346; D.IMG-250519KAM-347; D.IMG-250519KAM-348; D.IMG-250519KAM-349; D.IMG-250519KAM-350; D.IMG-250519KAM-351; D.IMG-250519KAM-352; D.IMG-250519KAM-353; D.IMG-250519KAM-354; D.IMG-250519KAM-355; D.IMG-250519KAM-356; D.IMG-250519KAM-357; D.IMG-250519KAM-358; D.IMG-250519KAM-359; D.IMG-250519KAM-360; D.IMG-250519KAM-361; D.IMG-250519KAM-362; D.IMG-250519KAM-363; D.IMG-250519KAM-364; D.IMG-250519KAM-365; D.IMG-250519KAM-366; D.IMG-250519KAM-367; D.IMG-250519KAM-368; D.IMG-250519KAM-369; D.IMG-250519KAM-370; D.IMG-250519KAM-371; D.IMG-250519KAM-372; D.IMG-250519KAM-373; D.IMG-250519KAM-374; D.IMG-250519KAM-375; D.IMG-250519KAM-376; D.IMG-250519KAM-377; D.IMG-250519KAM-378; D.IMG-250519KAM-379; D.IMG-250519KAM-380; D.IMG-250519KAM-381; D.IMG-250519KAM-382; D.IMG-250519KAM-383; D.IMG-250519KAM-384; D.IMG-250519KAM-385; D.IMG-250519KAM-386; D.IMG-250519KAM-387; D.IMG-250519KAM-388; D.IMG-250519KAM-389; D.IMG-250519KAM-390; D.IMG-250519KAM-391; D.IMG-250519KAM-392; D.IMG-250519KAM-393; D.IMG-250519KAM-394; D.IMG-250519KAM-395; D.IMG-250519KAM-396; D.IMG-250519KAM-397; D.IMG-250519KAM-398; D.IMG-250519KAM-399; D.IMG-250519KAM-400; D.IMG-250519KAM-401; D.IMG-250519KAM-402; D.IMG-250519KAM-403; D.IMG-250519KAM-404; D.IMG-250519KAM-405; D.IMG-250519KAM-406; D.IMG-250519KAM-407; D.IMG-250519KAM-408; D.IMG-250519KAM-409; D.IMG-250519KAM-410; D.IMG-250519KAM-411; D.IMG-250519KAM-412; D.IMG-250519KAM-413; D.IMG-250519KAM-414; D.IMG-250519KAM-415; D.IMG-250519KAM-416; D.IMG-250519KAM-417; D.IMG-250519KAM-418; D.IMG-250519KAM-419; D.IMG-250519KAM-420; D.IMG-250519KAM-421; D.IMG-250519KAM-422; D.IMG-250519KAM-423; D.IMG-250519KAM-424; D.IMG-250519KAM-425; D.IMG-250519KAM-426; D.IMG-250519KAM-427; D.IMG-250519KAM-428; D.IMG-250519KAM-429; D.IMG-250519KAM-430; D.IMG-250519KAM-431; D.IMG-250519KAM-432; D.IMG-250519KAM-433; D.IMG-250519KAM-434; D.IMG-250519KAM-435; D.IMG-250519KAM-436; D.IMG-250519KAM-437; D.IMG-250519KAM-438; D.IMG-250519KAM-439; D.IMG-250519KAM-440; D.IMG-250519KAM-441; D.IMG-250519KAM-442; D.IMG-250519KAM-443; D.IMG-250519KAM-444; D.IMG-250519KAM-445; D.IMG-250519KAM-446; D.IMG-250519KAM-447; D.IMG-250519KAM-448; D.IMG-250519KAM-449; D.IMG-250519KAM-450; D.IMG-250519KAM-451; D.IMG-250519KAM-452; D.IMG-250519KAM-453; D.IMG-250519KAM-454; D.IMG-250519KAM-455; D.IMG-250519KAM-456; D.IMG-250519KAM-457; D.IMG-250519KAM-458; D.IMG-250519KAM-459; D.IMG-250519KAM-460; D.IMG-250519KAM-461; D.IMG-250519KAM-462; D.IMG-250519KAM-463; D.IMG-250519KAM-464; D.IMG-250519KAM-465; D.IMG-250519KAM-466; D.IMG-250519KAM-467; D.IMG-250519KAM-468; D.IMG-250519KAM-469; D.IMG-250519KAM-470; D.IMG-250519KAM-471; D.IMG-250519KAM-472; D.IMG-250519KAM-473; D.IMG-250519KAM-474; D.IMG-250519KAM-475; D.IMG-250519KAM-476; D.IMG-250519KAM-477; D.IMG-250519KAM-478; D.IMG-250519KAM-479; D.IMG-250519KAM-480; D.IMG-250519KAM-481; D.IMG-250519KAM-482; D.IMG-250519KAM-483; D.IMG-250519KAM-484; D.IMG-250519KAM-485; D.IMG-250519KAM-486; D.IMG-250519KAM-487; D.IMG-250519KAM-488; D.IMG-250519KAM-489; D.IMG-250519KAM-490; D.IMG-250519KAM-491; D.IMG-250519KAM-492; D.IMG-250519KAM-493; D.IMG-250519KAM-494; D.IMG-250519KAM-495; D.IMG-250519KAM-496; D.IMG-250519KAM-497; D.IMG-250519KAM-498; D.IMG-250519KAM-499; D.IMG-250519KAM-500; D.IMG-250519KAM-501; D.IMG-250519KAM-502; D.IMG-250519KAM-503; D.IMG-250519KAM-504; D.IMG-250519KAM-505; D.IMG-250519KAM-506; D.IMG-250519KAM-507; D.IMG-250519KAM-508; D.IMG-250519KAM-509; D.IMG-250519KAM-510; D.IMG-250519KAM-511; D.IMG-250519KAM-512; D.IMG-250519KAM-513; D.IMG-250519KAM-514; D.IMG-250519KAM-515; D.IMG-250519KAM-516; D.IMG-250519KAM-517; D.IMG-250519KAM-518; D.IMG-250519KAM-519; D.IMG-250519KAM-520; D.IMG-250519KAM-521; D.IMG-250519KAM-522; D.IMG-250519KAM-523; D.IMG-250519KAM-524; D.IMG-250519KAM-525; D.IMG-250519KAM-526; D.IMG-250519KAM-527; D.IMG-250519KAM-528; D.IMG-250519KAM-529; D.IMG-250519KAM-530; D.IMG-250519KAM-531; D.IMG-250519KAM-532; D.IMG-250519KAM-533; D.IMG-250519KAM-534; D.IMG-250519KAM-535; D.IMG-250519KAM-536; D.IMG-250519KAM-537; D.IMG-250519KAM-538; D.IMG-250519KAM-539; D.IMG-250519KAM-540; D.IMG-250519KAM-541; D.IMG-250519KAM-542; D.IMG-250519KAM-543; D.IMG-250519KAM-544; D.IMG-250519KAM-545; D.IMG-250519KAM-546; D.IMG-250519KAM-547; D.IMG-250519KAM-548; D.IMG-250519KAM-549; D.IMG-250519KAM-550; D.IMG-250519KAM-551; D.IMG-250519KAM-552; D.IMG-250519KAM-553; D.IMG-250519KAM-554; D.IMG-250519KAM-555; D.IMG-250519KAM-556; D.IMG-250519KAM-557; D.IMG-250519KAM-558; D.IMG-250519KAM-559; D.IMG-250519KAM-560; D.IMG-250519KAM-561; D.IMG-250519KAM-562; D.IMG-250519KAM-563; D.IMG-250519KAM-564; D.IMG-250519KAM-565; D.IMG-250519KAM-566; D.IMG-250519KAM-567; D.IMG-250519KAM-568; D.IMG-250519KAM-569; D.IMG-250519KAM-570; D.IMG-250519KAM-571; D.IMG-250519KAM-572; D.IMG-250519KAM-573; D.IMG-250519KAM-574; D.IMG-250519KAM-575; D.IMG-250519KAM-576; D.IMG-250519KAM-577; D.IMG-250519KAM-578; D.IMG-250519KAM-579; D.IMG-250519KAM-580; D.IMG-250519KAM-581; D.IMG-250519KAM-582; D.IMG-250519KAM-583; D.IMG-250519KAM-584; D.IMG-250519KAM-585; D.IMG-250519KAM-586; D.IMG-250519KAM-587; D.IMG-250519KAM-588; D.IMG-250519KAM-589; D.IMG-250519KAM-590; D.IMG-250519KAM-591; D.IMG-250519KAM-592; D.IMG-250519KAM-593; D.IMG-250519KAM-594; D.IMG-250519KAM-595; D.IMG-250519KAM-596 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-251118KAM-1 | Figure-S5-Morphology_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure-S5-Morphology_analysis.xlsx?download=1&preview=1 | 69d5fc7b269159f7cd351a669cdebd95 | ImageJ | Elena Cambria | D.IMG-251118KAM-241; D.IMG-251118KAM-242; D.IMG-251118KAM-243; D.IMG-251118KAM-244; D.IMG-251118KAM-245; D.IMG-251118KAM-246; D.IMG-251118KAM-247; D.IMG-251118KAM-248; D.IMG-251118KAM-249; D.IMG-251118KAM-250; D.IMG-251118KAM-251; D.IMG-251118KAM-252; D.IMG-251118KAM-253; D.IMG-251118KAM-254; D.IMG-251118KAM-255; D.IMG-251118KAM-256; D.IMG-251118KAM-257; D.IMG-251118KAM-258; D.IMG-251118KAM-259; D.IMG-251118KAM-260; D.IMG-251118KAM-261; D.IMG-251118KAM-262; D.IMG-251118KAM-263; D.IMG-251118KAM-264; D.IMG-251118KAM-265; D.IMG-251118KAM-266; D.IMG-251118KAM-267; D.IMG-251118KAM-268; D.IMG-251118KAM-269; D.IMG-251118KAM-270; D.IMG-251118KAM-271; D.IMG-251118KAM-272; D.IMG-251118KAM-273; D.IMG-251118KAM-274; D.IMG-251118KAM-275; D.IMG-251118KAM-276; D.IMG-251118KAM-277; D.IMG-251118KAM-278; D.IMG-251118KAM-279; D.IMG-251118KAM-280; D.IMG-251118KAM-281; D.IMG-251118KAM-282; D.IMG-251118KAM-283; D.IMG-251118KAM-284; D.IMG-251118KAM-285; D.IMG-251118KAM-286; D.IMG-251118KAM-287; D.IMG-251118KAM-288; D.IMG-251118KAM-289; D.IMG-251118KAM-290; D.IMG-251118KAM-291; D.IMG-251118KAM-292; D.IMG-251118KAM-293; D.IMG-251118KAM-294; D.IMG-251118KAM-295; D.IMG-251118KAM-296; D.IMG-251118KAM-297; D.IMG-251118KAM-298; D.IMG-251118KAM-299; D.IMG-251118KAM-300; D.IMG-251118KAM-301; D.IMG-251118KAM-302; D.IMG-251118KAM-303; D.IMG-251118KAM-304; D.IMG-251118KAM-305; D.IMG-251118KAM-306; D.IMG-251118KAM-307; D.IMG-251118KAM-308; D.IMG-251118KAM-309; D.IMG-251118KAM-310; D.IMG-251118KAM-311; D.IMG-251118KAM-312; D.IMG-251118KAM-313; D.IMG-251118KAM-314; D.IMG-251118KAM-315; D.IMG-251118KAM-316; D.IMG-251118KAM-317; D.IMG-251118KAM-318; D.IMG-251118KAM-319; D.IMG-251118KAM-320; D.IMG-251118KAM-321; D.IMG-251118KAM-322; D.IMG-251118KAM-323; D.IMG-251118KAM-324; D.IMG-251118KAM-325; D.IMG-251118KAM-326; D.IMG-251118KAM-327; D.IMG-251118KAM-328; D.IMG-251118KAM-329; D.IMG-251118KAM-330; D.IMG-251118KAM-331; D.IMG-251118KAM-332; D.IMG-251118KAM-333; D.IMG-251118KAM-334; D.IMG-251118KAM-335; D.IMG-251118KAM-336; D.IMG-251118KAM-337; D.IMG-251118KAM-338; D.IMG-251118KAM-339; D.IMG-251118KAM-340; D.IMG-251118KAM-341; D.IMG-251118KAM-342; D.IMG-251118KAM-343; D.IMG-251118KAM-344; D.IMG-251118KAM-345; D.IMG-251118KAM-346; D.IMG-251118KAM-347; D.IMG-251118KAM-348; D.IMG-251118KAM-349; D.IMG-251118KAM-350; D.IMG-251118KAM-351; D.IMG-251118KAM-352; D.IMG-251118KAM-353; D.IMG-251118KAM-354; D.IMG-251118KAM-355; D.IMG-251118KAM-356; D.IMG-251118KAM-357; D.IMG-251118KAM-358; D.IMG-251118KAM-359; D.IMG-251118KAM-360 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-251118KAM-2 | Figure-S5- Permeability_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure-S5-%20Permeability_analysis.xlsx?download=1&preview=1 | 9aec3d2134d832e21a9740bd1618bb1f | ImageJ | Elena Cambria | D.IMG-251118KAM-241; D.IMG-251118KAM-242; D.IMG-251118KAM-243; D.IMG-251118KAM-244; D.IMG-251118KAM-245; D.IMG-251118KAM-246; D.IMG-251118KAM-247; D.IMG-251118KAM-248; D.IMG-251118KAM-249; D.IMG-251118KAM-250; D.IMG-251118KAM-251; D.IMG-251118KAM-252; D.IMG-251118KAM-253; D.IMG-251118KAM-254; D.IMG-251118KAM-255; D.IMG-251118KAM-256; D.IMG-251118KAM-257; D.IMG-251118KAM-258; D.IMG-251118KAM-259; D.IMG-251118KAM-260; D.IMG-251118KAM-261; D.IMG-251118KAM-262; D.IMG-251118KAM-263; D.IMG-251118KAM-264; D.IMG-251118KAM-265; D.IMG-251118KAM-266; D.IMG-251118KAM-267; D.IMG-251118KAM-268; D.IMG-251118KAM-269; D.IMG-251118KAM-270; D.IMG-251118KAM-271; D.IMG-251118KAM-272; D.IMG-251118KAM-273; D.IMG-251118KAM-274; D.IMG-251118KAM-275; D.IMG-251118KAM-276; D.IMG-251118KAM-277; D.IMG-251118KAM-278; D.IMG-251118KAM-279; D.IMG-251118KAM-280; D.IMG-251118KAM-281; D.IMG-251118KAM-282; D.IMG-251118KAM-283; D.IMG-251118KAM-284; D.IMG-251118KAM-285; D.IMG-251118KAM-286; D.IMG-251118KAM-287; D.IMG-251118KAM-288; D.IMG-251118KAM-289; D.IMG-251118KAM-290; D.IMG-251118KAM-291; D.IMG-251118KAM-292; D.IMG-251118KAM-293; D.IMG-251118KAM-294; D.IMG-251118KAM-295; D.IMG-251118KAM-296; D.IMG-251118KAM-297; D.IMG-251118KAM-298; D.IMG-251118KAM-299; D.IMG-251118KAM-300; D.IMG-251118KAM-301; D.IMG-251118KAM-302; D.IMG-251118KAM-303; D.IMG-251118KAM-304; D.IMG-251118KAM-305; D.IMG-251118KAM-306; D.IMG-251118KAM-307; D.IMG-251118KAM-308; D.IMG-251118KAM-309; D.IMG-251118KAM-310; D.IMG-251118KAM-311; D.IMG-251118KAM-312; D.IMG-251118KAM-313; D.IMG-251118KAM-314; D.IMG-251118KAM-315; D.IMG-251118KAM-316; D.IMG-251118KAM-317; D.IMG-251118KAM-318; D.IMG-251118KAM-319; D.IMG-251118KAM-320; D.IMG-251118KAM-321; D.IMG-251118KAM-322; D.IMG-251118KAM-323; D.IMG-251118KAM-324; D.IMG-251118KAM-325; D.IMG-251118KAM-326; D.IMG-251118KAM-327; D.IMG-251118KAM-328; D.IMG-251118KAM-329; D.IMG-251118KAM-330; D.IMG-251118KAM-331; D.IMG-251118KAM-332; D.IMG-251118KAM-333; D.IMG-251118KAM-334; D.IMG-251118KAM-335; D.IMG-251118KAM-336; D.IMG-251118KAM-337; D.IMG-251118KAM-338; D.IMG-251118KAM-339; D.IMG-251118KAM-340; D.IMG-251118KAM-341; D.IMG-251118KAM-342; D.IMG-251118KAM-343; D.IMG-251118KAM-344; D.IMG-251118KAM-345; D.IMG-251118KAM-346; D.IMG-251118KAM-347; D.IMG-251118KAM-348; D.IMG-251118KAM-349; D.IMG-251118KAM-350; D.IMG-251118KAM-351; D.IMG-251118KAM-352; D.IMG-251118KAM-353; D.IMG-251118KAM-354; D.IMG-251118KAM-355; D.IMG-251118KAM-356; D.IMG-251118KAM-357; D.IMG-251118KAM-358; D.IMG-251118KAM-359; D.IMG-251118KAM-360 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-251118KAM-3 | Figure7-Angiogenesis_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure7-Angiogenesis_analysis.xlsx?download=1&preview=1 | 191f66d46bc8d744f752f0be4b9e1e4c | ImageJ | Elena Cambria | D.IMG-251118KAM-1; D.IMG-251118KAM-2; D.IMG-251118KAM-9; D.IMG-251118KAM-10; D.IMG-251118KAM-17; D.IMG-251118KAM-18; D.IMG-251118KAM-25; D.IMG-251118KAM-26; D.IMG-251118KAM-33; D.IMG-251118KAM-34; D.IMG-251118KAM-41; D.IMG-251118KAM-42; D.IMG-251118KAM-49; D.IMG-251118KAM-50; D.IMG-251118KAM-57; D.IMG-251118KAM-58; D.IMG-251118KAM-65; D.IMG-251118KAM-66; D.IMG-251118KAM-73; D.IMG-251118KAM-74; D.IMG-251118KAM-81; D.IMG-251118KAM-82; D.IMG-251118KAM-95; D.IMG-251118KAM-96; D.IMG-251118KAM-97; D.IMG-251118KAM-98; D.IMG-251118KAM-111; D.IMG-251118KAM-112; D.IMG-251118KAM-119; D.IMG-251118KAM-120; D.IMG-251118KAM-128; D.IMG-251118KAM-129; D.IMG-251118KAM-136; D.IMG-251118KAM-137; D.IMG-251118KAM-144; D.IMG-251118KAM-145; D.IMG-251118KAM-152; D.IMG-251118KAM-153; D.IMG-251118KAM-160; D.IMG-251118KAM-161; D.IMG-251118KAM-168; D.IMG-251118KAM-169; D.IMG-251118KAM-176; D.IMG-251118KAM-177; D.IMG-251118KAM-184; D.IMG-251118KAM-185; D.IMG-251118KAM-192; D.IMG-251118KAM-193; D.IMG-251118KAM-206; D.IMG-251118KAM-207; D.IMG-251118KAM-208; D.IMG-251118KAM-209; D.IMG-251118KAM-222; D.IMG-251118KAM-223; D.IMG-251118KAM-224; D.IMG-251118KAM-225; D.IMG-251118KAM-232; D.IMG-251118KAM-233; D.IMG-251118KAM-240 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-251118KAM-4 | Figure7-Morphology_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure7-Morphology_analysis.xlsx?download=1&preview=1 | f966d3061ff51dbbaa1325c13409d191 | ImageJ | Elena Cambria | D.IMG-251118KAM-3; D.IMG-251118KAM-4; D.IMG-251118KAM-5; D.IMG-251118KAM-6; D.IMG-251118KAM-7; D.IMG-251118KAM-8; D.IMG-251118KAM-11; D.IMG-251118KAM-12; D.IMG-251118KAM-13; D.IMG-251118KAM-14; D.IMG-251118KAM-15; D.IMG-251118KAM-16; D.IMG-251118KAM-19; D.IMG-251118KAM-20; D.IMG-251118KAM-21; D.IMG-251118KAM-22; D.IMG-251118KAM-23; D.IMG-251118KAM-24; D.IMG-251118KAM-27; D.IMG-251118KAM-28; D.IMG-251118KAM-29; D.IMG-251118KAM-30; D.IMG-251118KAM-31; D.IMG-251118KAM-32; D.IMG-251118KAM-35; D.IMG-251118KAM-36; D.IMG-251118KAM-37; D.IMG-251118KAM-38; D.IMG-251118KAM-39; D.IMG-251118KAM-40; D.IMG-251118KAM-43; D.IMG-251118KAM-44; D.IMG-251118KAM-45; D.IMG-251118KAM-46; D.IMG-251118KAM-47; D.IMG-251118KAM-48; D.IMG-251118KAM-51; D.IMG-251118KAM-52; D.IMG-251118KAM-53; D.IMG-251118KAM-54; D.IMG-251118KAM-55; D.IMG-251118KAM-56; D.IMG-251118KAM-59; D.IMG-251118KAM-60; D.IMG-251118KAM-61; D.IMG-251118KAM-62; D.IMG-251118KAM-63; D.IMG-251118KAM-64; D.IMG-251118KAM-67; D.IMG-251118KAM-68; D.IMG-251118KAM-69; D.IMG-251118KAM-70; D.IMG-251118KAM-71; D.IMG-251118KAM-72; D.IMG-251118KAM-75; D.IMG-251118KAM-76; D.IMG-251118KAM-77; D.IMG-251118KAM-78; D.IMG-251118KAM-79 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-251118KAM-5 | Figure7-Permeability_analysis.xlsx | https://zenodo.org/records/15475937/files/Figure7-Permeability_analysis.xlsx?download=1&preview=1 | 073b33f34cfeca25dcadeba87813808f | ImageJ | Elena Cambria | D.IMG-251118KAM-3; D.IMG-251118KAM-4; D.IMG-251118KAM-5; D.IMG-251118KAM-6; D.IMG-251118KAM-7; D.IMG-251118KAM-8; D.IMG-251118KAM-11; D.IMG-251118KAM-12; D.IMG-251118KAM-13; D.IMG-251118KAM-14; D.IMG-251118KAM-15; D.IMG-251118KAM-16; D.IMG-251118KAM-19; D.IMG-251118KAM-20; D.IMG-251118KAM-21; D.IMG-251118KAM-22; D.IMG-251118KAM-23; D.IMG-251118KAM-24; D.IMG-251118KAM-27; D.IMG-251118KAM-28; D.IMG-251118KAM-29; D.IMG-251118KAM-30; D.IMG-251118KAM-31; D.IMG-251118KAM-32; D.IMG-251118KAM-35; D.IMG-251118KAM-36; D.IMG-251118KAM-37; D.IMG-251118KAM-38; D.IMG-251118KAM-39; D.IMG-251118KAM-40; D.IMG-251118KAM-43; D.IMG-251118KAM-44; D.IMG-251118KAM-45; D.IMG-251118KAM-46; D.IMG-251118KAM-47; D.IMG-251118KAM-48; D.IMG-251118KAM-51; D.IMG-251118KAM-52; D.IMG-251118KAM-53; D.IMG-251118KAM-54; D.IMG-251118KAM-55; D.IMG-251118KAM-56; D.IMG-251118KAM-59; D.IMG-251118KAM-60; D.IMG-251118KAM-61; D.IMG-251118KAM-62; D.IMG-251118KAM-63; D.IMG-251118KAM-64; D.IMG-251118KAM-67; D.IMG-251118KAM-68; D.IMG-251118KAM-69; D.IMG-251118KAM-70; D.IMG-251118KAM-71; D.IMG-251118KAM-72; D.IMG-251118KAM-75; D.IMG-251118KAM-76; D.IMG-251118KAM-77; D.IMG-251118KAM-78; D.IMG-251118KAM-79 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-260105KAM-1 | 2D_Immunofluorescence_quantification_FigS1.xlsx | https://zenodo.org/records/15475937/files/2D_Immunofluorescence_quantification_FigS1.xlsx?download=1&preview=1 | f13a69b24381cd70fbec5f47b80a30f6 | ImageJ | Elena Cambria | D.IMG-260105KAM-1; D.IMG-260105KAM-2; D.IMG-260105KAM-3; D.IMG-260105KAM-4; D.IMG-260105KAM-5; D.IMG-260105KAM-6; D.IMG-260105KAM-7; D.IMG-260105KAM-8; D.IMG-260105KAM-9; D.IMG-260105KAM-10; D.IMG-260105KAM-11; D.IMG-260105KAM-12; D.IMG-260105KAM-13; D.IMG-260105KAM-14; D.IMG-260105KAM-15; D.IMG-260105KAM-16; D.IMG-260105KAM-17; D.IMG-260105KAM-18 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
| A.IMG-260105KAM-2 | FigureS5_ManualDiameter.xlsx | https://zenodo.org/records/15475937/files/FigureS5_ManualDiameter.xlsx?download=1&preview=1 | 374b61e9f618cc8489cb445694fcccd1 | ImageJ | Elena Cambria | D.IMG-251118KAM-241; D.IMG-251118KAM-242; D.IMG-251118KAM-243; D.IMG-251118KAM-244; D.IMG-251118KAM-245; D.IMG-251118KAM-246; D.IMG-251118KAM-247; D.IMG-251118KAM-248; D.IMG-251118KAM-249; D.IMG-251118KAM-250; D.IMG-251118KAM-251; D.IMG-251118KAM-252; D.IMG-251118KAM-253; D.IMG-251118KAM-254; D.IMG-251118KAM-255; D.IMG-251118KAM-256; D.IMG-251118KAM-257; D.IMG-251118KAM-258; D.IMG-251118KAM-259; D.IMG-251118KAM-260; D.IMG-251118KAM-261; D.IMG-251118KAM-262; D.IMG-251118KAM-263; D.IMG-251118KAM-264; D.IMG-251118KAM-265; D.IMG-251118KAM-266; D.IMG-251118KAM-267; D.IMG-251118KAM-268; D.IMG-251118KAM-269; D.IMG-251118KAM-270; D.IMG-251118KAM-271; D.IMG-251118KAM-272; D.IMG-251118KAM-273; D.IMG-251118KAM-274; D.IMG-251118KAM-275; D.IMG-251118KAM-276; D.IMG-251118KAM-277; D.IMG-251118KAM-278; D.IMG-251118KAM-279; D.IMG-251118KAM-280; D.IMG-251118KAM-281; D.IMG-251118KAM-282; D.IMG-251118KAM-283; D.IMG-251118KAM-284; D.IMG-251118KAM-285; D.IMG-251118KAM-286; D.IMG-251118KAM-287; D.IMG-251118KAM-288; D.IMG-251118KAM-289; D.IMG-251118KAM-290; D.IMG-251118KAM-291; D.IMG-251118KAM-292; D.IMG-251118KAM-293; D.IMG-251118KAM-294; D.IMG-251118KAM-295; D.IMG-251118KAM-296; D.IMG-251118KAM-297; D.IMG-251118KAM-298; D.IMG-251118KAM-299; D.IMG-251118KAM-300; D.IMG-251118KAM-301; D.IMG-251118KAM-302; D.IMG-251118KAM-303; D.IMG-251118KAM-304; D.IMG-251118KAM-305; D.IMG-251118KAM-306; D.IMG-251118KAM-307; D.IMG-251118KAM-308; D.IMG-251118KAM-309; D.IMG-251118KAM-310; D.IMG-251118KAM-311; D.IMG-251118KAM-312; D.IMG-251118KAM-313; D.IMG-251118KAM-314; D.IMG-251118KAM-315; D.IMG-251118KAM-316; D.IMG-251118KAM-317; D.IMG-251118KAM-318; D.IMG-251118KAM-319; D.IMG-251118KAM-320; D.IMG-251118KAM-321; D.IMG-251118KAM-322; D.IMG-251118KAM-323; D.IMG-251118KAM-324; D.IMG-251118KAM-325; D.IMG-251118KAM-326; D.IMG-251118KAM-327; D.IMG-251118KAM-328; D.IMG-251118KAM-329; D.IMG-251118KAM-330; D.IMG-251118KAM-331; D.IMG-251118KAM-332; D.IMG-251118KAM-333; D.IMG-251118KAM-334; D.IMG-251118KAM-335; D.IMG-251118KAM-336; D.IMG-251118KAM-337; D.IMG-251118KAM-338; D.IMG-251118KAM-339; D.IMG-251118KAM-340; D.IMG-251118KAM-341; D.IMG-251118KAM-342; D.IMG-251118KAM-343; D.IMG-251118KAM-344; D.IMG-251118KAM-345; D.IMG-251118KAM-346; D.IMG-251118KAM-347; D.IMG-251118KAM-348; D.IMG-251118KAM-349; D.IMG-251118KAM-350; D.IMG-251118KAM-351; D.IMG-251118KAM-352; D.IMG-251118KAM-353; D.IMG-251118KAM-354; D.IMG-251118KAM-355; D.IMG-251118KAM-356; D.IMG-251118KAM-357; D.IMG-251118KAM-358; D.IMG-251118KAM-359; D.IMG-251118KAM-360 | P.KAM-250519-V2_EC_Myofibroblast_Imaging_Analysis.docx | ||
